Covered recipient · General Payments record
SUSAN M KEMP
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$1,795.12
- Reported across 48 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $519.91 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| SK Life Science, Inc. | $143.54 | 3 |
| Neurelis, Inc. | $85.90 | 4 |
| UCB, Inc. | $72.33 | 3 |
| EISAI INC. | $56.93 | 2 |
| Genentech USA, Inc. | $46.33 | 1 |
| BAXTER HEALTHCARE | $41.76 | 1 |
| ABIOMED | $32.99 | 1 |
| Acerta Pharma LLC | $23.13 | 1 |
| Lilly USA, LLC | $17.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABIOMED | $32.99 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142203157 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.13 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104772228 | CMS |
| Baxter Healthcare | $41.76 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120632800 | CMS |
| Eisai Inc. | $24.16 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110822729 | CMS |
| Eisai Inc. | $32.77 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110822731 | CMS |
| Genentech USA, Inc. | $46.33 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133190699 | CMS |
| Lilly USA, LLC | $17.00 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135967130 | CMS |
| Neurelis, Inc. | $19.50 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145665833 | CMS |
| Neurelis, Inc. | $19.52 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145665835 | CMS |
| Neurelis, Inc. | $27.18 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145665837 | CMS |
| Neurelis, Inc. | $19.70 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145665839 | CMS |
| SK Life Science, Inc. | $110.00 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154121289 | CMS |
| SK Life Science, Inc. | $29.00 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154121271 | CMS |
| SK Life Science, Inc. | $4.54 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154121273 | CMS |
| UCB, Inc. | $22.81 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143351116 | CMS |
| UCB, Inc. | $21.04 | 09/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143351120 | CMS |
| UCB, Inc. | $28.48 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143351125 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.